Spire Wealth Management’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-50
Closed -$2.55K – 2251
2024
Q2
$2.55K Buy
+50
New +$2.48K ﹤0.01% 1966
2022
Q3
– Sell
-60
Closed -$3K – 2533
2022
Q2
$3K Buy
+60
New +$2.76K ﹤0.01% 2292
2022
Q1
– Sell
-1,228
Closed -$69K – 2821
2021
Q4
$69K Hold
1,228
– – ﹤0.01% 1573
2021
Q3
$58K Hold
1,228
– – ﹤0.01% 1408
2021
Q2
$57K Hold
1,228
– – ﹤0.01% 1428
2021
Q1
$49K Buy
+1,228
New +$48.5K ﹤0.01% 1735

Other funds holding RXL

Spire Wealth Management's RXL Position: Q3 2024 in Review

Spire Wealth Management sold out of ProShares Ultra Health Care (RXL) in Q3 2024, closing a stake of 50 shares — an estimated $2.55K sold.

Spire Wealth Management first reported a position in RXL in Q1 2021 and held it in 6 quarters. The position peaked at $69K in Q4 2021. 20 funds tracked by Wall St. Rank hold RXL as of Q3 2024.

  • Spire Wealth Management reported no remaining ProShares Ultra Health Care position as of Q3 2024 after selling out during the quarter.
  • Spire Wealth Management sold 50 ProShares Ultra Health Care shares in Q3 2024, an estimated $2.55K.
  • Spire Wealth Management first reported a position in ProShares Ultra Health Care in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's ProShares Ultra Health Care position peaked at $69K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2024.

Based on Spire Wealth Management's 13F filing for Q3 2024, filed 15 Oct 2024.